• <tr id="iccci"><code id="iccci"></code></tr>
  • <center id="iccci"><sup id="iccci"></sup></center>
  • <tr id="iccci"><input id="iccci"></input></tr><tr id="iccci"></tr>
  • <legend id="iccci"></legend><legend id="iccci"></legend>
    您好!欢迎访问上海易汇生物科技有限公司网站!
    全国服务咨询热线:

    18501609238

    当前位置:首页 > 产品中心 > 基因测序 > 生物试剂盒 > Illumina Kits 20018621Illumina 二代测序组合试剂盒

    Illumina 二代测序组合试剂盒

    简要描述:Sequencing Kits/ Microarray Kits/Informatics Products
    Illumina 测序组合试剂盒
    Illumina 二代测序组合试剂盒

    • 产品型号:Illumina Kits 20018621
    • 厂商性质:生产厂家
    • 更新时间:2025-03-27
    • 访  问  量:1244

    详细介绍

    品牌illumina/美国因美纳规格1 kit
    供货周期两周主要用途小型全基因组测序 组合试剂 试剂盒
    应用领域医疗卫生,化工,生物产业,制药/生物制药

    Illumina 二代测序组合试剂盒

    Illumina 二代测序组合试剂盒

    "Illumina/TruSight Tumor 170 Kit, For Use with NextSeq plus Watson for Genomics/20018621/1 Ea

    " 20018621 Illumina 产品编号: 20018621美  元  价: $0.00会  员  价: 待定品       牌: Illumina产       地: 美国公       司: Illumina, Inc.产品分类: 其它>其它试剂>芯片公司分类: Clinical Research Products "Product Highlights:

    TruSight Tumor 170, a next-generation sequencing assay designed to cover 170 genes associated with common solid tumors, is an enrichment-based targeted panel that simultaneously analyzes DNA and RNA, covering a wide range of genes and variant types. The comprehensive nature provides laboratories with a deep view into the genetics of cancer.


    Comprehensive Coverage of Cancer-Related Variants

    Assessment of fusions, splice variants, insertions/deletions and single-nucleotide variants (SNVs), and amplifications in one assay using DNA and RNA creates efficiencies in sample usage, time, and cost.

    Accurate Results from Low-Quality Samples1

    Variant detection with as little as 40 ng DNA and RNA input, and as low as 5% mutant allele frequency, maximizes the results from precious formalin-fixed paraffin-embedded (FFPE) samples.

    Integrated, Streamlined Workflow

    DNA and RNA are prepared in parallel with an integrated workflow following DNA shearing/CDNA synthesis.

    Specifications:

    Assay Time ~2 days (Library Prep)

    Hands-On Time ~10.5 hours

    Input Quantity 40 ng DNA and/or RNA

    Method Targeted RNA Sequencing,Targeted DNA Sequencing

    Variant Class Single Nucleotide Polymorphisms (SNPs),Gene Fusions,Somatic Variants,Structural Variants,Insertions-Deletions (indels),Copy Number Variants (CNVs)

    Specialized Sample Types FFPE,Low Input

    System Compatibility NextSeq 550,NextSeq 500,HiSeq 2500

    Technology Sequencing

    Species Category Human

    Cancer Type Solid Tumor

    Scientific Posters:

    AACR 2017: TruSight Tumor 170 and Tumor Mutational Burden

    Results of analysis indicate that TruSight Tumor 170, with comprehensive coverage of cancer-related genes, shows high concordance with whole exome sequencing for accurate assessment of tumor mutational burden.


    Learn More


    AACR 2017: TruSight Tumor 170 and Solid Tumor Profiling Analytical Performance with FFPE Samples

    Standard extractions from FFPE embedded samples provide sufficient material (40ng) in >95% of samples that were extracted by Illumina. This data shows that the TruSight Tumor 170 panel is a robust assay that generates passing sample QC data in >85% of samples with varying quality, and in >95% of samples that have quality metrics that fall within the recommendations for the kit.


    Learn More


    AACR 2017: TruSight Tumor 170 for Small Nucleotide Variations and Gene Amplifications in FFPE DNA Samples

    TruSight Tumor 170 can achieve high sensitivity and specificity for the detection of somatic variants (small variants and CNVs) from DNA extracted from FFPE tissues.


    Learn More


    AACR 2017: TruSight Tumor 170 for Fusions and Splice Variants in FFPE RNA Tumor Samples

    Through examining limit of detection in the context of RNA expression, this study shows that TruSight Tumor 170 provides high sensitivity and specificity in RNA variant calling down to 5 copies of transcript per ng of input.


    Learn More"

    Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供产品与应用资讯

    Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。

    Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

    Illumina 二代测序组合试剂盒


    咨询illumina MiSeq测序试剂盒等产品欢迎您致电 上海易汇生物科技有限公司:1850 1609 238张经理




    产品咨询

    留言框

    • 产品:

    • 您的单位:

    • 您的姓名:

    • 联系电话:

    • 常用邮箱:

    • 省份:

    • 详细地址:

    • 补充说明:

    • 验证码:

      请输入计算结果(填写阿拉伯数字),如:三加四=7
    上海易汇生物科技有限公司
    地址:上海市奉贤区金大公路8218号1幢
    邮箱:1006909781@qq.com
    传真:QQ1006909781
    关注我们
    欢迎您关注我们的微信公众号了解更多信息:
    欢迎您关注我们的微信公众号
    了解更多信息
    中文字幕在线亚洲二区 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>